Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00115739
Status:
TERMINATED
Last Update Posted:
2014-04-21
First Post:
2005-06-23
Brief Title:
Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
University of Michigan Rogel Cancer Center
Organization Data
Organization:
University of Michigan Rogel Cancer Center
Class:
OTHER
Study ID:
UMCC 2003-044
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Michigan Rogel Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
Francis Frank Worden
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Michigan Rogel Cancer Center
Old Name:
None
Old Organization:
None